Metformin use is associated with reduced odds of new-onset International Classification of Diseases (ICD) coding of neovascular age-related macular degeneration (nAMD), according to a study published ...

Metformin use is associated with reduced odds of new-onset International Classification of Diseases (ICD) coding of ...

Some less common but serious side effects of gabapentin include suicidal thoughts, allergic reactions, and serious breathing ...

New research finds metformin may not treat long COVID symptoms despite early promise. Learn what studies reveal about long COVID treatment and prevention.

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

Overall survival in men with metastatic castration-resistant prostate cancer treated with olaparib or lutetium-177-PSMA-617 following prior systemic therapy. Carboplatin in patients with metastatic ...

It’s worth the weight — loss, that is. Despite their blockbuster popularity, GLP-1 medications come with a handful of side effects, mainly along the lines of gastrointestinal issues like nausea and ...

A massive review of 23 randomized trials found that statins do not cause the vast majority of side effects listed on their labels. Memory problems, depression, sleep issues, weight gain, and many ...

Benefits of statins greatly outweigh risks, study leader says Wrongly attributed side effects may discourage use by patients and doctors Regulators should change statin labeling, researchers say Feb 5 ...

The long list of side effects associated with statins is vastly overstated, according to the most rigorous assessment of the evidence to date. This is prompting calls for the drugs’ packaging to be ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Far fewer people who could benefit from statins ...

The popularity of GLP-1 weight-loss drugs has seen a seismic shift in just over a year. Not long ago, they were primarily used for diabetes. But now, that’s changing. In some markets, such as the US, ...